Pharmaceutical company Inotiv hit by ransomware attack

Inotiv, a pharmaceutical company, has officially notified the Securities and Exchange Commission (SEC) about a significant disruption to its business operations following a ransomware attack. Hackers successfully compromised and encrypted Inotiv’s internal systems, leading to operational challenges that have impacted the company’s ability to function effectively. The breach has raised concerns regarding data security and the potential implications for stakeholders. Inotiv is currently working to assess the full extent of the damage and implement measures to restore its systems and safeguard against future attacks.

The ransomware incident has highlighted the increasing threat of cyberattacks within the pharmaceutical sector, prompting Inotiv to take immediate action to mitigate risks. As the company navigates this crisis, it remains committed to transparency and will keep the SEC and its stakeholders informed of any developments. The attack serves as a stark reminder of the vulnerabilities that organisations face in today’s digital landscape. Inotiv’s response will be crucial in rebuilding trust and ensuring the integrity of its operations moving forward.